470 related articles for article (PubMed ID: 26576925)
1. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
Katorcha E; Makarava N; Savtchenko R; Baskakov IV
Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
[TBL] [Abstract][Full Text] [Related]
2. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
[TBL] [Abstract][Full Text] [Related]
3. Role of sialylation of N-linked glycans in prion pathogenesis.
Makarava N; Baskakov IV
Cell Tissue Res; 2023 Apr; 392(1):201-214. PubMed ID: 35088180
[TBL] [Abstract][Full Text] [Related]
4. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
Makarava N; Chang JC; Baskakov IV
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
[TBL] [Abstract][Full Text] [Related]
5. Sialylation Controls Prion Fate
Srivastava S; Katorcha E; Daus ML; Lasch P; Beekes M; Baskakov IV
J Biol Chem; 2017 Feb; 292(6):2359-2368. PubMed ID: 27998976
[TBL] [Abstract][Full Text] [Related]
6. Post-conversion sialylation of prions in lymphoid tissues.
Srivastava S; Makarava N; Katorcha E; Savtchenko R; Brossmer R; Baskakov IV
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):E6654-62. PubMed ID: 26627256
[TBL] [Abstract][Full Text] [Related]
7. Role of sialylation in prion disease pathogenesis and prion structure.
Baskakov IV
Prog Mol Biol Transl Sci; 2020; 175():31-52. PubMed ID: 32958238
[TBL] [Abstract][Full Text] [Related]
8. Altered prion protein glycosylation in the aging mouse brain.
Goh AX; Li C; Sy MS; Wong BS
J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
[TBL] [Abstract][Full Text] [Related]
9. Reversible off and on switching of prion infectivity via removing and reinstalling prion sialylation.
Katorcha E; Daus ML; Gonzalez-Montalban N; Makarava N; Lasch P; Beekes M; Baskakov IV
Sci Rep; 2016 Sep; 6():33119. PubMed ID: 27609323
[TBL] [Abstract][Full Text] [Related]
10. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
11. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
12. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
13. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
[TBL] [Abstract][Full Text] [Related]
14. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
Bate C; Nolan W; Williams A
J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
16. Analyses of N-linked glycans of PrP
Katorcha E; Baskakov IV
FEBS J; 2017 Nov; 284(21):3727-3738. PubMed ID: 28898525
[TBL] [Abstract][Full Text] [Related]
17. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
Norstrom EM; Mastrianni JA
J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
19. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
20. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
